CRIS Current Research Information System

BORIANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.277
EU - Europa 20.215
AS - Asia 20.073
SA - Sud America 1.313
AF - Africa 1.086
Continente sconosciuto - Info sul continente non disponibili 804
OC - Oceania 28
Totale 68.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.019
VN - Vietnam 6.272
GB - Regno Unito 5.312
SG - Singapore 5.211
CN - Cina 4.658
IT - Italia 3.303
DE - Germania 2.890
UA - Ucraina 1.939
FR - Francia 1.458
HK - Hong Kong 1.363
NL - Olanda 1.237
SE - Svezia 1.194
RU - Federazione Russa 1.141
IN - India 1.108
BR - Brasile 976
IE - Irlanda 580
EE - Estonia 446
JP - Giappone 409
ZA - Sudafrica 398
CI - Costa d'Avorio 239
FI - Finlandia 236
SC - Seychelles 178
BD - Bangladesh 167
KR - Corea 157
AR - Argentina 146
CA - Canada 131
TG - Togo 119
PH - Filippine 106
TH - Thailandia 76
CH - Svizzera 75
IQ - Iraq 70
BG - Bulgaria 69
MX - Messico 60
JO - Giordania 58
BE - Belgio 57
ID - Indonesia 52
AT - Austria 50
TR - Turchia 50
EC - Ecuador 49
PL - Polonia 48
GR - Grecia 47
NG - Nigeria 47
PK - Pakistan 43
TW - Taiwan 39
IR - Iran 38
UZ - Uzbekistan 37
CL - Cile 35
SA - Arabia Saudita 34
CO - Colombia 30
PY - Paraguay 29
LB - Libano 28
ES - Italia 25
EG - Egitto 24
JM - Giamaica 20
AU - Australia 19
MY - Malesia 19
MA - Marocco 18
RO - Romania 18
CZ - Repubblica Ceca 16
HR - Croazia 15
UY - Uruguay 15
PE - Perù 14
VE - Venezuela 14
KE - Kenya 12
NP - Nepal 11
OM - Oman 11
DZ - Algeria 10
SN - Senegal 10
TN - Tunisia 10
KZ - Kazakistan 9
CR - Costa Rica 8
ET - Etiopia 8
HN - Honduras 8
AZ - Azerbaigian 7
EU - Europa 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
PT - Portogallo 6
NO - Norvegia 5
PR - Porto Rico 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
GT - Guatemala 4
HU - Ungheria 4
IL - Israele 4
KG - Kirghizistan 4
LU - Lussemburgo 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
BY - Bielorussia 3
GP - Guadalupe 3
LT - Lituania 3
MD - Moldavia 3
MU - Mauritius 3
Totale 67.953
Salva come PNG Salva come JPEG
Città #
Southend 4.731
Singapore 3.512
Fairfield 2.538
Ashburn 2.116
San Jose 1.697
Jacksonville 1.384
Ho Chi Minh City 1.329
Hong Kong 1.291
Wilmington 1.283
Woodbridge 1.166
Seattle 1.147
Princeton 1.112
Chandler 1.098
Houston 1.080
Hanoi 1.015
Cambridge 869
Santa Clara 850
Dong Ket 788
Council Bluffs 706
Ann Arbor 659
Kerkrade 652
Boardman 601
Dublin 579
Lauterbourg 553
Westminster 507
Padova 505
Nanjing 491
Beijing 447
Frankfurt am Main 419
Los Angeles 383
Tokyo 373
Hefei 342
Eygelshoven 338
Berlin 308
Milan 262
Medford 256
Saint Petersburg 254
Jinan 243
Abidjan 239
Shenyang 230
Buffalo 222
Helsinki 220
Mülheim 215
San Diego 189
New York 186
Bologna 185
Changsha 181
Mahé 160
Rome 158
Hebei 157
Dallas 156
Da Nang 155
Nanchang 149
Haiphong 136
Bremen 122
Turin 120
Lomé 119
Redondo Beach 119
São Paulo 115
Guangzhou 110
Tianjin 110
Seoul 107
Jiaxing 102
Shanghai 93
Des Moines 88
Olalla 88
Hangzhou 85
Verona 82
Zhengzhou 80
Yubileyny 78
Norwalk 74
The Dalles 73
Dearborn 67
Ningbo 67
Biên Hòa 64
Sofia 63
Phoenix 60
Hải Dương 59
Munich 59
Chicago 58
Falls Church 58
Haikou 58
Amman 56
Brussels 52
Can Tho 52
Florence 52
Ninh Bình 52
Thái Nguyên 51
Ha Long 49
London 48
Mountain View 48
Naples 47
Quận Bình Thạnh 44
San Venanzo 44
Nuremberg 43
Taizhou 43
Abeokuta 42
Lanzhou 42
Bengaluru 40
Bern 40
Totale 44.045
Salva come PNG Salva come JPEG
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.719
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.121
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 333
Incidenza e fattori predittivi di fibrillazione atriale post operatoria nei riceventi di trapianto renale 326
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation 319
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 311
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 300
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 290
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 279
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 264
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 264
Effects of cardiac resynchronization therapy on coronary blood flow: evaluation by transthoracic Doppler echocardiography. Poster European Congress of Cardiology 2007 255
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 254
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 252
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 251
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 247
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 232
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 232
Atrial fibrillation: it is better to be alone than in bad company! 231
AF burden is important - Fact or fiction? 230
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 224
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 218
Aritimie cardiache, morte cardiaca improvvisa, sincope 217
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 214
La tachicardiomiopatia: una revisione della letteratura 211
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 208
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 207
The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker 206
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 206
Electrocardiographic remodeling during cardiac resynchronization therapy 204
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 204
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 204
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 203
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients. 201
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 200
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 200
Automatic verification of ventricular stimulation: fusion management algorithm 198
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 197
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 195
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 194
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 194
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 194
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 194
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 192
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 191
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 190
Heart failure after myocardial revascularization: Risk markers. 189
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 188
Atrial fibrillation ablation: beyond electro-mechanical matters 187
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 187
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 185
Automatic management of left ventricular stimulation: hints for technologic improvement. 185
Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. 184
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 182
Implantation of cardioverter-defibrillator: Effects on shoulder function. 181
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 180
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 179
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 178
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 178
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 178
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 178
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 177
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 176
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 176
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 175
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 175
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 175
Technical Suitability of Implantable Cardiac Devices for Recreational Diving 175
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 174
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 174
The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. 173
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 173
Rate control in AFFIRM: considerations about the clinical implications. 172
Solution to a crushing dosage problem? 172
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 172
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 172
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 171
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 171
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 170
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 170
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 168
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 168
Can we improve risk stratification for thromboembolic events in atrial fibirillation by combining arrhythmia presence and duration with CHADS2 score? Poster European Congress of Cardiology 2008 168
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 168
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 167
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 166
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter 166
Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke 166
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 165
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. 165
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 164
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. 163
A randomised comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from bradycardia and atrial fibrillation and implanted with a DDDRP device 161
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. 161
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 161
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 161
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 160
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 160
Atrial fibrillation and heart failure: does one epidemic feed he other? 160
Totale 22.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.818 0 377 511 628 774 554 146 603 236 254 1.164 1.571
2022/20236.922 851 887 354 956 380 378 212 349 1.139 335 655 426
2023/20241.655 136 286 114 122 176 276 120 88 82 108 57 90
2024/20257.529 241 1.806 622 643 1.395 391 433 132 72 287 144 1.363
2025/202619.491 2.065 1.500 1.905 1.274 1.782 2.106 2.123 1.442 2.921 1.138 540 695
2026/20271.082 510 572 0 0 0 0 0 0 0 0 0 0
Totale 68.796